Financhill
Buy
52

CNS Quote, Financials, Valuation and Earnings

Last price:
$62.73
Seasonality move :
3.87%
Day range:
$62.34 - $64.43
52-week range:
$58.80 - $102.57
Dividend yield:
3.96%
P/E ratio:
19.67x
P/S ratio:
5.83x
P/B ratio:
5.81x
Volume:
482.7K
Avg. volume:
488.5K
1-year change:
-38.22%
Market cap:
$3.2B
Revenue:
$514.2M
EPS (TTM):
$3.18

Analysts' Opinion

  • Consensus Rating
    Cohen & Steers, Inc. (New York) has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $74.33, Cohen & Steers, Inc. (New York) has an estimated upside of 18.65% from its current price of $62.65.
  • Price Target Downside
    According to analysts, the lowest downside price target is $71.00 representing 100% downside risk from its current price of $62.65.

Fair Value

  • According to the consensus of 1 analyst, Cohen & Steers, Inc. (New York) has 18.65% upside to fair value with a price target of $74.33 per share.

CNS vs. S&P 500

  • Over the past 5 trading days, Cohen & Steers, Inc. (New York) has underperformed the S&P 500 by -1.87% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Cohen & Steers, Inc. (New York) does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Cohen & Steers, Inc. (New York) has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Cohen & Steers, Inc. (New York) reported revenues of $141.7M.

Earnings Growth

  • Cohen & Steers, Inc. (New York) has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Cohen & Steers, Inc. (New York) reported earnings per share of $0.81.
Enterprise value:
3.3B
EV / Invested capital:
4.54x
Price / LTM sales:
5.83x
EV / EBIT:
16.83x
EV / Revenue:
5.90x
PEG ratio (5yr expected):
1.04x
EV / Free cash flow:
14.66x
Price / Operating cash flow:
14.49x
Enterprise value / EBITDA:
15.93x
Gross Profit (TTM):
$479.9M
Return On Assets:
21.42%
Net Income Margin (TTM):
30.65%
Return On Equity:
29.77%
Return On Invested Capital:
23.88%
Operating Margin:
35%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $489M $491.3M $553.8M $132.4M $141.7M
Gross Profit $414.2M $422.1M $479.9M $114.9M $122.9M
Operating Income $169.2M $193.6M $194.1M $63.8M $49.6M
EBITDA $188.5M $208.5M $205M $66.6M $52.1M
Diluted EPS $2.66 $2.68 $3.18 $0.77 $0.81
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $290M $301.5M $302.6M $373.8M $366.6M
Total Assets $468.6M $506.3M $673.9M $727.8M $801.6M
Current Liabilities $110.9M $97.5M $83.9M $72.3M $79.5M
Total Liabilities $138M $113.2M $217.6M $215.2M $222.4M
Total Equity $330.6M $393.2M $456.3M $512.6M $579.3M
Total Debt $27.1M $15.6M $133.3M $140.6M $140.3M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $190.4M $171.6M $230.2M $49.4M $77M
Cash From Investing -$92.5M -$126.7M -$92.1M -$29.5M -$42M
Cash From Financing -$131.8M -$68.8M -$153M -$29.8M -$32.2M
Free Cash Flow $143M $150.7M $222.8M $48M $74.5M
CNS
Sector
Market Cap
$3.2B
$555.2M
Price % of 52-Week High
61.08%
90.06%
Dividend Yield
3.96%
1.64%
Shareholder Yield
4.58%
3.16%
1-Year Price Total Return
-38.22%
1.45%
Beta (5-Year)
1.291
0.481
Dividend yield:
3.96%
Annualized payout:
$2.36
Payout ratio:
76.66%
Growth streak:
2 years

Technicals

8-day SMA
Buy
Level $62.53
200-day SMA
Sell
Level $73.98
Bollinger Bands (100)
Sell
Level 64.95 - 74.19
Chaikin Money Flow
Sell
Level -4.9M
20-day SMA
Sell
Level $63.39
Relative Strength Index (RSI14)
Sell
Level 43.70
ADX Line
Sell
Level 20.38
Williams %R
Neutral
Level -41.0413
50-day SMA
Sell
Level $66.02
MACD (12, 26)
Sell
Level -1.33
25-day Aroon Oscillator
Sell
Level -56
On Balance Volume
Neutral
Level 976.8K

Financial Scores

Buy
Altman Z-Score (Annual)
Level (11.8048)
Buy
CA Score (Annual)
Level (1.1468)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-2.8456)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (10)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Cohen & Steers, Inc. is a holding company, which operates as an investment manager specializing in liquid real assets, which include real estate securities, listed infrastructure, commodities, natural resource equities, preferred securities, and other income solutions. It manages investment vehicles, such as institutional accounts, open-end funds and closed-end funds. The company was founded by Martin Cohen and Robert Hamilton Steers in 1986 and is headquartered in New York, NY.

Stock Forecast FAQ

In the current month, CNS has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CNS average analyst price target in the past 3 months is $74.33.

  • Where Will Cohen & Steers, Inc. (New York) Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Cohen & Steers, Inc. (New York) share price will rise to $74.33 per share over the next 12 months.

  • What Do Analysts Say About Cohen & Steers, Inc. (New York)?

    Analysts are divided on their view about Cohen & Steers, Inc. (New York) share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cohen & Steers, Inc. (New York) is a Sell and believe this share price will drop from its current level to $71.00.

  • What Is Cohen & Steers, Inc. (New York)'s Price Target?

    The price target for Cohen & Steers, Inc. (New York) over the next 1-year time period is forecast to be $74.33 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CNS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Cohen & Steers, Inc. (New York) is a Buy. 1 of 1 analysts rates the stock a Buy at this time.

  • How Can I Buy Shares Of CNS?

    You can purchase shares of Cohen & Steers, Inc. (New York) via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cohen & Steers, Inc. (New York) shares.

  • What Is The Cohen & Steers, Inc. (New York) Share Price Today?

    Cohen & Steers, Inc. (New York) was last trading at $62.73 per share. This represents the most recent stock quote for Cohen & Steers, Inc. (New York). Yesterday, Cohen & Steers, Inc. (New York) closed at $62.65 per share.

  • How To Buy Cohen & Steers, Inc. (New York) Stock Online?

    In order to purchase Cohen & Steers, Inc. (New York) stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is up 18.9% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock